Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver regeneration using a hybrid artificial liver support system.

H Mizumoto1, K Funatsu

  • 1Department of Chemical Engineering, Faculty of Engineering, Kyushu University, Higashi-ku, Fukuoka, Japan.

Artificial Organs
|January 15, 2004
PubMed
Summary

Two novel hybrid artificial liver support systems (HALSS) using hepatocyte organoids show promise for treating liver failure. These systems effectively supported liver function and aided recovery in preclinical models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of famotidine on blood carnitine levels and L-carnitine supplementation dose in tube-fed patients with severe motor and intellectual disabilities.

Die Pharmazie·2025
Same author

Prolonged lidocaine metabolizing activity of primary hepatocytes with spheroid culture using polyurethane foam as a culture substratum.

Cytotechnology·2012
Same author

Vitronectin enhances adhesion force and t-PA production of weakly adherent 293 cells exposed to a shear stress.

Cytotechnology·2008
Same author

Formation of porcine hepatocyte spherical multicellular aggregates (spheroids) and analysis of drug metabolic functions.

Cytotechnology·2008
Same author

Formation of cylindrical multicellular aggregate (cylindroid) and expression of liver specific functions of primary rat hepatocytes.

Cytotechnology·2008
Same author

Hepatic differentiation of embryonic stem cells in HF/organoid culture.

Transplantation proceedings·2008

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Hepatology

Background:

  • Liver failure poses a significant clinical challenge, necessitating innovative treatment strategies.
  • Current treatments like liver transplantation have limitations, including donor scarcity and immune rejection.
  • Artificial liver support systems aim to bridge the gap until transplantation or native liver regeneration.

Purpose of the Study:

  • To develop and evaluate two types of hybrid artificial liver support systems (HALSS) utilizing hepatocyte organoid culture.
  • To assess the in vitro longevity and liver-specific functions of the developed HALSS.
  • To investigate the efficacy of these HALSS in preclinical models of liver failure.

Main Methods:

  • Development of Polyurethane Foam-Hybrid Artificial Liver Support System (PUF-HALSS) with hepatocytes forming spheroids in PUF pores.

Related Experiment Videos

  • Development of Liver Lobule-like Structure-Hybrid Artificial Liver Support System (LLS-HALSS) using hollow fibers and hepatocyte organoids formed by centrifugation.
  • In vitro culture of hepatocyte organoids within both HALSS modules to assess function and longevity.
  • Preclinical application of PUF-HALSS in a pig model of liver failure.
  • Evaluation of PUF- and LLS-HALSS in a rat model of reversible hepatic failure to assess liver regeneration support.

    • Main Results:

    • PUF-HALSS maintained liver-specific functions in vitro for at least ten days.
    • LLS-HALSS maintained liver-specific functions in vitro for at least two months.
    • Both PUF- and LLS-HALSS demonstrated effectiveness in supporting liver function in preclinical models.
    • The systems contributed to the stabilization of general conditions and recovery from liver failure states in animal models.

    Conclusions:

    • The developed hybrid artificial liver support systems (HALSS) show significant potential for treating liver failure.
    • These systems can effectively support liver function and promote recovery, offering a viable option until liver transplantation or regeneration.
    • Further clinical investigation is warranted to establish the therapeutic efficacy of these advanced artificial liver devices.